MAUNA KEA TECHNOLOGIES (GB:0P5I)

LSE:0P5I

0P5I

MAUNA KEA TECHNOLOGIES

RESEARCH TOOLSreports

Want to see GB:0P5I full AI Analyst Report?

MAUNA KEA TECHNOLOGIES (0P5I) Price & Analysis

1 Followers

0P5I Stock Chart & Stats

€0.07

-€0.01(-6.06%)

At close: Jan 06 4:00 PM EST

€0.07

-€0.01(-6.06%)

Day’s Range― - ―

52-Week Range€0.07 - €0.23

Previous CloseN/A

Volume1.68K

Average Volume (3M)4.97K

Market Cap

€33.43M

Enterprise Value€21.53M

Total Cash (Recent Filing)€4.97M

Total Debt (Recent Filing)€12.08M

Price to Earnings (P/E)1.2

Beta2.02

Next Earnings

Oct 08, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.02

Shares Outstanding192,097,270

10 Day Avg. Volume5,801

30 Day Avg. Volume4,974

Financial Highlights & Ratios

PEG Ratio>-0.01

Price to Book (P/B)-2.65

Price to Sales (P/S)1.55

P/FCF Ratio-3.24

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)-0.02

Revenue Forecast (FY)€7.75M

Bulls Say, Bears Say

Bulls Say

High Gross MarginsA sustained ~75% gross margin implies strong unit economics for the CLE platform and probes. High product-level margins create room for scalable profitability as sales and installed base grow, supporting long-term margin recovery once operating leverage and fixed-cost absorption improve.

Recurring Consumables / Installed-Base ModelThe business model links capital equipment placement to repeatable consumable probe revenue per procedure. This installed-base + consumables model can generate durable, predictable revenue streams over months as clinical adoption expands, improving lifetime customer economics.

Material Debt ReductionSignificant deleveraging in 2025 reduces near-term refinancing pressure and interest burden. Lower gross debt improves solvency headroom and increases the company's ability to fund growth initiatives or withstand revenue variability without immediate external financing.

Bears Say

Negative Operating Profitability & Cash BurnDeeply negative operating margins together with persistent negative operating and free cash flow indicate the core business still consumes cash. Over months this necessitates ongoing financing, constrains reinvestment in sales and R&D, and raises execution risk for scaling the installed base.

Negative Shareholders' EquityA negative equity base reflects multi-year accumulated losses and weak capitalization. This limits borrowing capacity, increases refinancing and insolvency risk, and can force dilutive recapitalizations that impair long-term investor returns and strategic flexibility.

Earnings Quality & Revenue VolatilityA large accounting profit not supported by operating cash flow suggests one-time items or noncash gains, raising sustainability doubts. Coupled with sharp year-to-year revenue swings, this undermines predictability of future earnings and cash generation over the medium term.

0P5I FAQ

What was MAUNA KEA TECHNOLOGIES’s price range in the past 12 months?

MAUNA KEA TECHNOLOGIES lowest share price was €0.07 and its highest was €0.23 in the past 12 months.

What is MAUNA KEA TECHNOLOGIES’s market cap?

MAUNA KEA TECHNOLOGIES’s market cap is €33.43M.

When is MAUNA KEA TECHNOLOGIES’s upcoming earnings report date?

MAUNA KEA TECHNOLOGIES’s upcoming earnings report date is Oct 08, 2026 which is in 140 days.

How were MAUNA KEA TECHNOLOGIES’s earnings last quarter?

MAUNA KEA TECHNOLOGIES released its earnings results on Apr 22, 2026. The company reported €0.19 earnings per share for the quarter, beating the consensus estimate of N/A by €0.19.

Is MAUNA KEA TECHNOLOGIES overvalued?

According to Wall Street analysts MAUNA KEA TECHNOLOGIES’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does MAUNA KEA TECHNOLOGIES pay dividends?

MAUNA KEA TECHNOLOGIES does not currently pay dividends.

What is MAUNA KEA TECHNOLOGIES’s EPS estimate?

MAUNA KEA TECHNOLOGIES’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does MAUNA KEA TECHNOLOGIES have?

MAUNA KEA TECHNOLOGIES has 192,097,270 shares outstanding.

What happened to MAUNA KEA TECHNOLOGIES’s price movement after its last earnings report?

MAUNA KEA TECHNOLOGIES reported an EPS of €0.19 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of MAUNA KEA TECHNOLOGIES?

Currently, no hedge funds are holding shares in GB:0P5I

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

MAUNA KEA TECHNOLOGIES

Mauna Kea Technologies SA, a medical device company, manufactures and sells medical devices in Europe and internationally. It offers range of medical devices in gastroenterology, pulmonology, and urology areas. Its product portfolio includes Cellvizio, a real-time in vivo cellular imaging platform which enables physicians to monitor progression of disease over time, assess point-in-time reactions, classify indeterminate areas, and guide surgical interventions. The company was incorporated in 2000 and is headquartered in Paris, France.